Bromfenac

Bromfenac

SCHEMBL57090

Nc1c(CC(=O)O)cccc1C(=O)c1ccc(Br)cc1.[NaH]

nearest known ligand 0.97

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PTGS1PTGS2

The experimentally established mechanism targets of Bromfenac. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
PTGS1 known ✓ P23219 1/20 0.97
PTGS2 known ✓ P35354 1/20 0.97
ABCB11 O95342 1/20 0.97
LMNA P02545 1/20 0.97
ADORA1 P30542 1/20 0.97
AKR1C3 P42330 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromfenac SCHEMBL15968905 1.00 ABCB11 (0.97) ABCB11LMNAPTGS1ADORA1PTGS2
Bromfenac SCHEMBL29023565 0.99 ABCB11 (0.94) ABCB11LMNAPTGS1ADORA1PTGS2
Bromfenac SCHEMBL14861906 0.99 ABCB11 (1.00) ABCB11LMNAPTGS1ADORA1PTGS2
Bromfenac SCHEMBL34411 0.99 ABCB11 (1.00) ABCB11LMNAPTGS1ADORA1PTGS2
Bromfenac SCHEMBL57092 0.97 ABCB11 (0.97) ABCB11LMNAPTGS1ADORA1PTGS2
Bromfenac SCHEMBL28429368 0.97 ABCB11 (0.97) ABCB11LMNAPTGS1ADORA1PTGS2
Bromfenac SCHEMBL28895435 0.97 ABCB11 (0.97) ABCB11LMNAPTGS1ADORA1PTGS2
Bromfenac SCHEMBL28429415 0.97 ABCB11 (0.97) ABCB11LMNAPTGS1ADORA1PTGS2
Bromfenac SCHEMBL28420990 0.97 ABCB11 (0.97) ABCB11LMNAPTGS1ADORA1PTGS2
Bromfenac SCHEMBL28429917 0.97 ABCB11 (0.97) ABCB11LMNAPTGS1ADORA1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111743858-B Pharmaceutical composition of bromfenac sodium 天津药业研究院股份有限公司 2023-06-27 CN claimed
CN-110885296-B Preparation method of bromfenac sodium 新发药业有限公司 2022-11-04 CN claimed
US-9561277-B2 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid SENJU PHARMACEUTICAL CO., LTD. (JP) 2017-02-07 US claimed
WO-2015170177-A1 AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID SENJU PHARMACEUTICAL CO., LTD. (JP) 2015-11-12 WO claimed
US-9144609-B2 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid SENJU PHARMACEUTICAL CO., LTD. (JP) 2015-09-29 US claimed
US-20150025149-A1 AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID SENJU PHARMACEUTICAL CO., LTD. (JP) 2015-01-22 US claimed
US-20150011634-A1 AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID SENJU PHARMACEUTICAL CO., LTD. (JP) 2015-01-08 US claimed
US-8927606-B1 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid SENJU PHARMACEUTICAL CO., LTD. (JP) 2015-01-06 US claimed
US-8871813-B2 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid SENJU PHARMACEUTICAL CO., LTD. (JP) 2014-10-28 US claimed
US-20140243413-A1 AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID SENJU PHARMACEUTICAL CO., LTD. (JP) 2014-08-28 US claimed
US-20140235721-A1 AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID SENJU PHARMACEUTICAL CO., LTD. (JP) 2014-08-21 US claimed
US-8754131-B2 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid SENJU PHARMACEUTICAL CO., LTD. (JP) 2014-06-17 US claimed
US-20140142183-A1 AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID SENJU PHARMACEUTICAL CO., LTD. (JP) 2014-05-22 US claimed
US-8669290-B2 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid SENJU PHARMACEUTICAL CO., LTD. (JP) 2014-03-11 US claimed
US-8497304-B2 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid SENJU PHARMACEUTICAL CO., LTD. (JP) 2013-07-30 US claimed
US-20130090384-A1 AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID SENJU PHARMACEUTICAL CO., LTD. (JP) 2013-04-11 US claimed
US-20120115957-A1 AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID SENJU PHARMACEUTICAL CO., LTD. (JP) 2012-05-10 US claimed
US-8129431-B2 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid SENJU PHARMACEUTICAL CO., LTD. (JP) 2012-03-06 US claimed
CN-115477611-B MRGPRX2 antagonists for the treatment of pseudoallergy 香港大学 2024-11-08 CN disclosed
US-4683242-A Transdermal treatment for pain and inflammation with 2-amino-3-aroylbenzeneacetic acids, salts and esters A. H. ROBINS COMPANY, INCORPORATED (US) 1987-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140243413-A1 AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID AADAT, TLR2, FFAR2 PTGS1 132/4885PTGS2 61/4885ABCB11 1324/4885
US-20140142183-A1 AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID PAOX, FFAR2, FFAR3 PTGS1 149/4885PTGS2 60/4885ABCB11 952/4885
US-20130090384-A1 AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID PAOX, FFAR2, FFAR3 PTGS1 149/4885PTGS2 60/4885ABCB11 952/4885
US-20140235721-A1 AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID PAOX, FFAR2, FFAR3 PTGS1 149/4885PTGS2 60/4885ABCB11 952/4885
US-20150025149-A1 AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID PAOX, FFAR2, FFAR3 PTGS1 149/4885PTGS2 60/4885ABCB11 952/4885
US-20150011634-A1 AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID PAOX, FFAR2, FFAR3 PTGS1 149/4885PTGS2 60/4885ABCB11 952/4885
US-20120115957-A1 AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID PAOX, FFAR2, FFAR3 PTGS1 149/4885PTGS2 60/4885ABCB11 952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.